NCT00618592

Brief Summary

The recent development of an oral carbohydrate drink for consumption prior to elective surgical procedures has been shown to improve insulin sensitivity. However, these studies have not investigated the use of this carbohydrate supplement in patients undergoing cardiac and spinal surgery. Hypothesis: The administration of 100g of carbohydrates the evening before and 50g of carbohydrates two hours before elective coronary artery bypass graft (CABG) or spinal surgery will reduce postoperative insulin resistance by 40% compared to those undergoing the standard of care of fasting the evening before and the day of surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

February 8, 2008

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 20, 2008

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2009

Completed
Last Updated

July 22, 2010

Status Verified

February 1, 2009

Enrollment Period

1.5 years

First QC Date

February 8, 2008

Last Update Submit

July 21, 2010

Conditions

Keywords

carbohydrate supplementationcardiac surgeryspine surgeryinsulin resistanceinsulin sensitivityshort insulin tolerance testHOMAoutcomes

Outcome Measures

Primary Outcomes (1)

  • Insulin sensitivity

    baseline and postoperatively

Secondary Outcomes (5)

  • Markers of inflammation e.g., CRP, IL-6, free fatty acids

    baseline, in ICU, and 24, 48 and 72 hours postoperatively

  • Glucose metabolism e.g., insulin-mediated glucose uptake and GLUT 4 translocation

    onset of surgery

  • Clinical outcomes e.g., length of stay in ICU and hospital, blood transfusions

    during surgery and postoperatively

  • Preoperative patient discomfort

    baseline and preoperatively

  • IGF-1

    baseline, in ICU and 24, 48 and 72 hours postoperatively

Study Arms (2)

CHO

EXPERIMENTAL
Dietary Supplement: PreOp carbohydrate drink

FAST

NO INTERVENTION

Interventions

PreOp carbohydrate drinkDIETARY_SUPPLEMENT

800 mL of PreOp evening before surgery, 400 mL at least two hours before surgery

Also known as: PreOp, Nutricia
CHO

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients undergoing elective coronary artery bypass graft or spinal (decompression and fusion) surgery
  • Ability to provide informed consent

You may not qualify if:

  • Patients undergoing associated cardiac procedures such as valve replacement or valve repair
  • Patients undergoing spinal surgery without fusion
  • Conditions likely to impair gastrointestinal motility or enhance gastrointestinal reflux
  • On medications likely to delay gastric emptying
  • BMI \> 40
  • Existing Type I or Type II diabetes
  • Participated in another study in the past 30 days
  • Entering surgery greater than five hours after ingestion of morning drink

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Michael's Hospital

Toronto, Ontario, M5B 1W8, Canada

Location

Related Publications (1)

  • Tran S, Wolever TM, Errett LE, Ahn H, Mazer CD, Keith M. Preoperative carbohydrate loading in patients undergoing coronary artery bypass or spinal surgery. Anesth Analg. 2013 Aug;117(2):305-13. doi: 10.1213/ANE.0b013e318295e8d1. Epub 2013 Jun 11.

MeSH Terms

Conditions

Insulin Resistance

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • C. David Mazer, MD

    Unity Health Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 8, 2008

First Posted

February 20, 2008

Study Start

February 1, 2008

Primary Completion

August 1, 2009

Study Completion

August 1, 2009

Last Updated

July 22, 2010

Record last verified: 2009-02

Locations